• Accueil >
  • Publications >
  • An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer

An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer

1 sept. 2016Virchows Archiv

DOI : 10.1007/s00428-016-1979-9

Auteurs

Jelle Wesseling, Corrado Tinterri, Anna Sapino, Fabrizio Zanconati, Martijn Lutke-Holzik, Bichlien Nguyen, Kenneth B Deck, Patrizia Querzoli, Tiziana Perin, Carmela Giardina, Gerhard Seitz, Jean-Marc Guinebretière, Julie Barone, Laura Dekker, Femke de Snoo, Lisette Stork-Sloots, Paul Roepman, Toru Watanabe, Pino Cusumano